Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy

Despite recent advances, cancer remains the primary killer on a global scale. Numerous forms of research have been conducted to discover novel and efficient anticancer medications. The complexity of breast cancer is a major challenge which is coupled with patient-to-patient variations and heterogene...

Full description

Bibliographic Details
Main Authors: Yedi Herdiana, Nasrul Wathoni, Dolih Gozali, Shaharum Shamsuddin, Muchtaridi Muchtaridi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/3/879
_version_ 1797609535634931712
author Yedi Herdiana
Nasrul Wathoni
Dolih Gozali
Shaharum Shamsuddin
Muchtaridi Muchtaridi
author_facet Yedi Herdiana
Nasrul Wathoni
Dolih Gozali
Shaharum Shamsuddin
Muchtaridi Muchtaridi
author_sort Yedi Herdiana
collection DOAJ
description Despite recent advances, cancer remains the primary killer on a global scale. Numerous forms of research have been conducted to discover novel and efficient anticancer medications. The complexity of breast cancer is a major challenge which is coupled with patient-to-patient variations and heterogeneity between cells within the tumor. Revolutionary drug delivery is expected to provide a solution to that challenge. Chitosan nanoparticles (CSNPs) have prospects as a revolutionary delivery system capable of enhancing anticancer drug activity and reducing negative impacts on normal cells. The use of smart drug delivery systems (SDDs) as delivering materials to improve the bioactivity of NPs and to understand the intricacies of breast cancer has garnered significant interest. There are many reviews about CSNPs that present various points of view, but they have not yet described a series in cancer therapy from cell uptake to cell death. With this description, we will provide a more complete picture for designing preparations for SDDs. This review describes CSNPs as SDDSs, enhancing cancer therapy targeting and stimulus response using their anticancer mechanism. Multimodal chitosan SDDs as targeting and stimulus response medication delivery will improve therapeutic results.
first_indexed 2024-03-11T06:02:46Z
format Article
id doaj.art-f0284ed3f18b4208bcb047d438be5a21
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T06:02:46Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-f0284ed3f18b4208bcb047d438be5a212023-11-17T13:15:41ZengMDPI AGPharmaceutics1999-49232023-03-0115387910.3390/pharmaceutics15030879Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer TherapyYedi Herdiana0Nasrul Wathoni1Dolih Gozali2Shaharum Shamsuddin3Muchtaridi Muchtaridi4Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, IndonesiaDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, IndonesiaDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, IndonesiaSchool of Health Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, MalaysiaDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, IndonesiaDespite recent advances, cancer remains the primary killer on a global scale. Numerous forms of research have been conducted to discover novel and efficient anticancer medications. The complexity of breast cancer is a major challenge which is coupled with patient-to-patient variations and heterogeneity between cells within the tumor. Revolutionary drug delivery is expected to provide a solution to that challenge. Chitosan nanoparticles (CSNPs) have prospects as a revolutionary delivery system capable of enhancing anticancer drug activity and reducing negative impacts on normal cells. The use of smart drug delivery systems (SDDs) as delivering materials to improve the bioactivity of NPs and to understand the intricacies of breast cancer has garnered significant interest. There are many reviews about CSNPs that present various points of view, but they have not yet described a series in cancer therapy from cell uptake to cell death. With this description, we will provide a more complete picture for designing preparations for SDDs. This review describes CSNPs as SDDSs, enhancing cancer therapy targeting and stimulus response using their anticancer mechanism. Multimodal chitosan SDDs as targeting and stimulus response medication delivery will improve therapeutic results.https://www.mdpi.com/1999-4923/15/3/879nanocarriermultimodal deliverystimulus responsetargeting
spellingShingle Yedi Herdiana
Nasrul Wathoni
Dolih Gozali
Shaharum Shamsuddin
Muchtaridi Muchtaridi
Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
Pharmaceutics
nanocarrier
multimodal delivery
stimulus response
targeting
title Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
title_full Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
title_fullStr Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
title_full_unstemmed Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
title_short Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
title_sort chitosan based nano smart drug delivery system in breast cancer therapy
topic nanocarrier
multimodal delivery
stimulus response
targeting
url https://www.mdpi.com/1999-4923/15/3/879
work_keys_str_mv AT yediherdiana chitosanbasednanosmartdrugdeliverysysteminbreastcancertherapy
AT nasrulwathoni chitosanbasednanosmartdrugdeliverysysteminbreastcancertherapy
AT dolihgozali chitosanbasednanosmartdrugdeliverysysteminbreastcancertherapy
AT shaharumshamsuddin chitosanbasednanosmartdrugdeliverysysteminbreastcancertherapy
AT muchtaridimuchtaridi chitosanbasednanosmartdrugdeliverysysteminbreastcancertherapy